Colistimethate (marketed as Coly-Mycin M and generic products)
June 28th, 2007 · No Comments
FDA is investigating the connection between the use of pre-mixed liquid form of Colistimethate and death of a cystic fibrosis patient.
Tags: FDA · FDA Alerts
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.